Unraveling the Multifaceted Role of the miR-17-92 Cluster in Colorectal Cancer: From Mechanisms to Biomarker Potential
Open Access
- 28 February 2024
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (3) , 1832-1850
Abstract
Colorectal cancer (CRC) is a complex disease driven by intricate mechanisms, making it challenging to understand and manage. The miR-17-92 cluster has gained significant attention in CRC research due to its diverse functions and crucial role in various aspects of the disease. This cluster, consisting of multiple individual miRNAs, influences critical processes like tumor initiation, angiogenesis, metastasis, and the epithelial–mesenchymal transition (EMT). Beyond its roles in tumorigenesis and progression, miR-17-92′s dysregulation in CRC has substantial implications for diagnosis, prognosis, and treatment, including chemotherapy responsiveness. It also shows promise as a diagnostic and prognostic biomarker, offering insights into treatment responses and disease progression. This review provides a comprehensive overview of recent advancements and the context-dependent role of the miR-17-92 cluster in colorectal cancer, drawing from the latest high-quality published data. It summarizes the established mechanisms governing miR-17-92 expression and the molecular pathways under its influence. Furthermore, it examines instances where it functions as an oncogene or a tumor suppressor, elucidating how cellular contexts dictate its biological effects. Ultimately, miR-17-92 holds promise as a biomarker for prognosis and therapy response, as well as a potential target for cancer prevention and therapeutic interventions. In essence, this review underscores the multifaceted nature of miR-17-92 in CRC research, offering promising avenues for enhancing the management of CRC patients.Keywords
This publication has 88 references indexed in Scilit:
- Exosomal microRNA‐19b targets FBXW7 to promote colorectal cancer stem cell stemness and induce resistance to radiotherapyThe Kaohsiung Journal of Medical Sciences, 2021
- MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic reviewBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
- Environmental Influences in the Etiology of Colorectal Cancer: the Premise of MetabolomicsCurrent Pharmacology Reports, 2017
- Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgeryInternational Journal of Colorectal Disease, 2015
- Quantitatively Controlling Expression of miR-17∼92 Determines Colon Tumor Progression in a Mouse Tumor ModelThe American Journal of Pathology, 2014
- Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancerTumor Biology, 2013
- A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7Journal of Cancer Research and Clinical Oncology, 2012
- Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancerInternational Journal of Colorectal Disease, 2012
- Prognostic values of the miR‐17‐92 cluster and its paralogs in colon cancerJournal of Surgical Oncology, 2011
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancerInternational Journal of Cancer, 2010